header__brand

AAOMS Member Alerts

In order to keep effective drugs and devices available on the market for use by you and your patients, the FDA relies on the voluntary reporting of all adverse events. FDA uses the data to maintain its safety surveillance of all FDA-regulated products. Your report may be the critical action that prompts a modification in use or design of the product, improves the safety profile of the drug or device and leads to increased patient safety.

Member Alerts Date
FDA restricts use of codeine, tramadol in children Jul. 31, 2017
Cantrell Drug Company announces recall Jul. 31, 2017
Member Alert: Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine Hydrochloride Injection, USP Due to The Presence Of Particulate Matter Within a Single Vial Aug. 05, 2016
Member Alert:CDC Webinar Series Addresses Guidelines for Prescribing Opioids Jun. 16, 2016
Member Alert: New Safety Warnings Added to Prescription Opioid Medications Mar. 24, 2016
AAOMS Announces New Executive Director Feb. 08, 2016
FDA Safety Alert: Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength Oct. 16, 2015
Member Alert: Alere Initiates Voluntary URGENT PRODUCT RECALL of Alere INRatio 2 PT/INR Professional Test Strips Mar. 16, 2015
Member Alert: Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter Jan. 26, 2015
Member Alert: Reports of Serious Injuries from Bone Graft Substitutes Jan. 21, 2015
Member Alert: AAOMS & ADA respond to LA Times article Jan. 13, 2015
Member Alert: Heart Sync Inc. Issues Voluntary Device Correction for Multi-function Defibrillation Electrodes Dec. 08, 2014
Member Alert: Resources for addressing possible Ebola infected patients Oct. 16, 2014
Member Alert: ACS “Surgical Protocol for Possible or Confirmed Ebola Cases” heading Oct. 15, 2014
Member Alert: DePuy Synthes Craniomaxillofacial Distraction System: Class I Recall - May Reverse Directions After Surgery Aug. 28, 2014
Member Alert: FDA Reschedules Hydrocodone Combination Products from Schedule III to Schedule II Aug. 22, 2014
Member Alert: Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates Aug. 21, 2014
Member Alert: Baxter Initiates Voluntary Worldwide Recall of 4 Lots of IV Solutions Due to Presence Jul. 28, 2014
Member Alert: Manufacturers increasing cost of scarce saline solution Jul. 03, 2014
Member Alert: Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates Apr. 22, 2014
Member Alert: Glycopyrrolate Injection Shortage Feb. 10, 2014
Member Alert: Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing Jan. 15, 2014
Member Alert: FDA issues safety communication on HeartStart automated external defibrillators from Philips Healthcare Dec. 11, 2013
Member Alert: FDA to submit formal recommendation to reclassify hydrocodone combination products into Schedule II Oct. 25, 2013
Member Alert: Pallimed Solutions, Inc. Sterile Compound Products: Recall - Visible Particulates Observed Apr. 01, 2013
Member Alert: FDA Issues Class 1 Recall: Verathon GlideScope Video Laryngoscope - Breaking Across the Tip of the Blade Dec. 17, 2012
Member Alert: FDA reports safety risk from tissue recovered at the Pacific Coast Tissue Bank of Los Angeles, CA Nov. 16, 2012
Member Alert: FDA Recalls Accutron, Inc. Ultra PC% Cabinet Mount Flowmeters for Nitrous Oxide-Oxygen Sedation Systems Oct. 25, 2012
Member Alert: I-Flow ON-Q Pump with ONDEMAND Bolus Button: Class I Recall - Risk of Continuous Infusion at a Rate Greater Than Expected Sep. 05, 2012